Michael Sigal

17PUBLICATIONS
55CO-AUTHORS
AutoimmunityInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 31, 2026
Real-world data on clinical response to inflammatory bowel disease biological treatments in patients with concurrent primary sclerosing cholangitis: a case-control study.

|Sep 11, 2025
Defining the mucosal ecosystem: epithelial-mesenchymal interdependence in gastrointestinal health and disease.

Frances J England, Manqiang Lin, Michael Sigal

|May 03, 2025
Extrusion of BMP2+ surface colonocytes promotes stromal remodeling and tissue regeneration.

Julian Heuberger, Lichao Liu, Hilmar Berger

|Feb 26, 2025
Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis.

Jonas Wizenty, Michael Sigal

|Jan 13, 2025
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.

Dennyson Leandro M Fonseca, Maj Jäpel, Michael Adu Gyamfi

|Oct 25, 2024
p53 terminates the regenerative fetal-like state after colitis-associated injury.

Kimberly Hartl, Şafak Bayram, Alexandra Wetzel

Pageof 3

Frequent Collaborators

7 joint publications

Frank Tacke

7 joint publications

Hilmar Berger

5 joint publications

Julian Heuberger

4 joint publications

Thomas F Meyer